Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.
about
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cellsThe Chemistry and Pharmacology of Anatoxin-a and Related Homotropanes with respect to Nicotinic Acetylcholine ReceptorsCentral nicotinic receptors: structure, function, ligands, and therapeutic potential.First-Principles Determination of Molecular Conformations of Indolizidine (-)-235B' in SolutionA New and Efficient Approach to the Synthesis of Nicotine and Anabasine Analogues.First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution.DDT, epigenetic harm, and transgenerational environmental justice.Molecular determinants for competitive inhibition of alpha4beta2 nicotinic acetylcholine receptors.The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications.Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinitySynthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.N,N-disubstituted piperazines: synthesis and affinities at alpha4beta2(*) and alpha7(*) neuronal nicotinic acetylcholine receptors.A practical and efficient route for the highly enantioselective synthesis of mexiletine analogues and novel beta-thiophenoxy and pyridyl ethers.Highly enantioselective borane reduction of heteroaryl and heterocyclic ketoxime ethers catalyzed by novel spiroborate ester derived from diphenylvalinol: application to the synthesis of nicotine analogues.Molecular modeling of mono- and bis-quaternary ammonium salts as ligands at the alpha4beta2 nicotinic acetylcholine receptor subtype using nonlinear techniques.Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches.Spiroborate ester-mediated asymmetric synthesis of beta-hydroxy ethers and its conversion to highly enantiopure beta-amino ethersComputational analysis of the binding ability of heterocyclic and conformationally constrained epibatidine analogs in the neuronal nicotinic acetylcholine receptor.New analogues of epiboxidine incorporating the 4,5-dihydroisoxazole nucleus: synthesis, binding affinity at neuronal nicotinic acetylcholine receptors, and molecular modeling investigations.Alpha7 nicotinic acetylcholine receptor agonists: prediction of their binding affinity through a molecular mechanics Poisson-Boltzmann surface area approach.Computer-aided drug design applied to Parkinson targets.N, N -disubstituted piperazines and homopiperazines: synthesis and affinities at alpha4beta2* and alpha7* neuronal nicotinic acetylcholine receptors.Synthesis of Epibatidine-Related Δ2-Isoxazoline Derivatives and Evaluation of Their Binding Affinity at Neuronal Nicotinic Acetylcholine Receptors
P2860
Q24554359-09A08422-12BB-4C68-AA96-1D296F0D8782Q28972418-C82A0E09-676C-4CA9-9A37-149C8EF40DA9Q33273397-046691D8-9AD9-427E-8D9D-7C6DCF0021FBQ33551965-B2374858-E684-4CA4-8E7E-FA57D75407C0Q33611329-7B28C3DA-EF16-4AD4-82D2-682F5BF7973BQ33900007-2B5E785D-C8EF-4A95-A7A7-729EE99A9918Q34013317-06C790D4-DBD2-46EA-8FD9-F2DD490D8B2BQ34127939-418C1EC6-7D0E-4BA0-8DC4-B80AE235BD7AQ35025843-7C815F87-5F86-4BF1-8C7A-7E3A241DE705Q35112780-266A5ABD-9639-4E24-A34E-5DE942ED4FA4Q35238525-AFBDEAB6-4222-47D5-89F6-DE693295D8B9Q36825487-BCEF852E-51F7-475C-B5B4-5371827F31F5Q37111697-56FAF9C7-B4E8-498E-BFD4-401D2C647BC2Q37157444-FD8429D3-882C-48E8-9026-8CA2A14615DBQ37239443-3D9D2E82-B9FC-47B6-8AD7-ED299CD3103CQ37361760-2141F334-3DCF-4FBF-992D-966B04BD8909Q38709211-1BBD1B46-220C-4445-BC9E-98079915D1C9Q42592185-01A11784-B52A-4B63-833A-B7CE57B53A9FQ43651750-8E281A49-03A2-44AF-987D-B69D283E43E5Q46113352-C8AC3F5D-1E6A-441A-AB6F-FF411BCF1A83Q46597035-A6F6DEC6-027D-4B83-B015-E261DC09B6FEQ47658773-2CB5A13A-8FEF-4675-9D15-869205BEB0A8Q48298061-199C7C62-9569-416E-BE76-42D33D81D720Q58853571-598CB031-3006-407A-8C88-D03BCC323B24
P2860
Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@ast
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@en
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@nl
type
label
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@ast
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@en
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@nl
prefLabel
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@ast
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@en
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@nl
P356
P1476
Agonists at the alpha4beta2 ni ...... ships and molecular modelling.
@en
P2093
P304
P356
10.2174/0929867013373165
P577
2001-05-01T00:00:00Z